Memantine vs Nivolumab
Memantine vs Nivolumab: Overview
This comparison examines the pharmacological differences between Memantine and Nivolumab.
Mechanism of Action
Memantine: Non-competitive NMDA receptor antagonist.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Memantine β 60-80 hours; Nivolumab β 27 days.
Chemical Properties
Molecular Formula: Memantine β C12H21N.
Molecular Weight: Memantine β 179.3080 g/mol.
Type: Memantine β Small molecule; Nivolumab β Antibody.